 |
|
|
|
|
|
NEWS RELEASE:
FOR IMMEDIATE RELEASE:
|
|
|
MERGE HEALTHCARE ANNOUNCES USER GROUP MEETING FOR RIS,
PACS AND CLINICAL APPLICATION CUSTOMERS
Conference will be first User Group Meeting jointly planned by Merge and customers
Milwaukee, WI, October 1, 2007 – Merge Healthcare, (NASDAQ: MRGE; TSX: MRG), a leading medical imaging software and services provider, announced that it will hold its 2008 User Group Meeting for its RIS, PACS and Clinical Application customers, April 21 - 25, 2008, in Las Vegas, NV. The meeting, to be held at the MGM Grand Hotel & Casino, will include RIS, PACS and clinical software presentations by Merge Healthcare staff, as well as best practices sessions presented by Merge Healthcare customers. Additionally, participants will provide feedback on product roadmaps and will develop relationships with each other for post-meeting networking on issues pertaining to best practices, optimizing workflow and accelerating productivity in the post-DRA healthcare environment.
The 2008 meeting will be the fifth User Group Meeting and the first in which Merge Healthcare users will play a significant role in its planning and coordination. The opportunity for greater user involvement in the User Group Meeting and in the Merge Healthcare product roadmap and customer support and service issues were major outcomes of the 2007 User Group Meeting. These developments arose from an agreement between Merge and its customers to proceed with the formation of an independent user-controlled Merge Healthcare User Group.
"When users of any company’s solutions become a unified group, the potential for a productive dialogue becomes truly real – a two-way communication occurs that includes not just the company’s agenda, but ours too," said Shanda Coomes Bland, COO of Radiology & Diagnostic Imaging (Owensboro, KY) and a member of the User Group Foundation Committee. "This user-controlled independent user group also gives us a voice in areas such as the product roadmap and service/support issues and can serve in an advisory capacity regarding emerging market opportunities. In these areas, it can be truly a win-win for customers as well as Merge Healthcare."
# # #
Merge Healthcare is a market leader in the development and delivery of medical imaging and information management software and services. Our innovative software solutions use leading-edge imaging software technologies that accelerate market delivery for our OEM customers, while our end-user solutions improve our customers' productivity and enhance the quality of patient care they provide. For additional information, visit our website at www.mergehealthcare.com.
All trademarks appearing in this release are the property of Cedara Software Corp. and/or Merge Healthcare.
|
Attn: Beth Frost-Johnson
Merge Healthcare
6737 West Washington St.
Suite 2250
Milwaukee, WI 53214
|
|
|
|
|
|
| Except for the historical information herein, the matters discussed in this news release include forward-looking statements that may involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, the forward-looking statements based on a number of factors, including, but not limited to, the uncertainty created by, the adverse impact on relationships with customers, potential customers, suppliers and investors potentially resulting from, and other risks associated with, the changes in the Company’s senior management; costs, risks and effects of the investigation by the Audit Committee of the Board of Directors; the impact of the restatement of financial statements of the Company and other actions that may be taken or required as a result of such restatement; the Company's inability to timely file reports with the Securities and Exchange Commission; risks associated with the Company's inability to meet the requirements of The NASDAQ Stock Market for continued listing, including possible delisting; costs, risks and effects of legal proceedings and investigations, including the informal, non-public inquiry being conducted by the Securities and Exchange Commission and class action, derivative, and other lawsuits; risks in product and technology development, market acceptance of new products and continuing product demand, the impact of competitive products and pricing, ability to integrate acquisitions, changing economic conditions, credit and payment risks associated with end-user sales, dependence on major customers, dependence on key personnel, and other risk factors detailed in the Company’s filings with the Securities and Exchange Commission. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements contained herein to reflect future events, developments, or changed circumstances, or for any other reason.
|
|
|
